• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干眼症诊治的进展

Advances in understanding and managing dry eye disease.

作者信息

Lemp Michael A

机构信息

Department of Ophthalmology, Georgetown University School of Medicine, 4000 Cathedral Avenue NW, Washington, DC 20016, USA.

出版信息

Am J Ophthalmol. 2008 Sep;146(3):350-356. doi: 10.1016/j.ajo.2008.05.016. Epub 2008 Jul 2.

DOI:10.1016/j.ajo.2008.05.016
PMID:18599017
Abstract

PURPOSE

To present evidence from the literature and scientific meetings to support fundamental changes in concepts regarding the prevalence, pathogenesis, definition, diagnosis, management of dry eye disease (DED) and the prospects for the development of new therapies.

DESIGN

Analysis and clinical perspective of the literature and recent presentations.

METHODS

Review and interpretation of literature.

RESULTS

The tear film and ocular surface form an integrated physiologic unit linking the surface epithelia and secretory glands via a neural network. This sensory-driven network regulates secretory activity in quantity and composition, supporting the homeostasis of the system. The tear film forms a metastable covering between blinks, subserving clear vision, and maintains the health and turnover of the ocular surface cells. Disturbance of intrinsic factors such as increasing age; hormonal balance; systemic or local autoimmune disease, or both; systemic drugs or extrinsic factors including topical medications; environmental stress; contact lens wear; or refractive surgery result in a final common pathway of events at the tear film and ocular surface, resulting in DED. Diagnosis of DED and the design of clinical trials for new drugs have been hampered by a lack of correlation between signs and symptoms and flawed endpoints; successful new drug applications likely will require new approaches, such as the use of objective biomarkers for disease severity.

CONCLUSIONS

Recent advances in our knowledge of the causation of DED open opportunities for improving diagnosis and disease management and for developing new, more effective therapies to manage this widely prevalent and debilitating disease state.

摘要

目的

展示来自文献和科学会议的证据,以支持在干眼疾病(DED)的患病率、发病机制、定义、诊断、管理以及新疗法开发前景等概念方面的根本性变革。

设计

对文献和近期报告的分析及临床视角。

方法

对文献进行综述和解读。

结果

泪膜和眼表通过神经网络形成一个整合的生理单元,将表面上皮和分泌腺连接起来。这个由感觉驱动的网络调节分泌活动的数量和成分,维持系统的稳态。泪膜在眨眼之间形成一个亚稳态覆盖物,有助于清晰视力,并维持眼表细胞的健康和更新。内在因素如年龄增长、激素平衡、全身性或局部自身免疫性疾病(或两者兼有)、全身性药物,或外在因素包括局部用药、环境压力、佩戴隐形眼镜或屈光手术等的干扰,会导致泪膜和眼表出现一系列最终的共同事件,从而引发DED。DED的诊断以及新药临床试验的设计一直受到症状与体征缺乏相关性以及终点存在缺陷的阻碍;成功的新药应用可能需要新的方法,例如使用客观生物标志物来评估疾病严重程度。

结论

我们对DED病因认识的最新进展为改善诊断和疾病管理以及开发新的、更有效的疗法来治疗这种广泛流行且使人衰弱的疾病状态提供了机会。

相似文献

1
Advances in understanding and managing dry eye disease.干眼症诊治的进展
Am J Ophthalmol. 2008 Sep;146(3):350-356. doi: 10.1016/j.ajo.2008.05.016. Epub 2008 Jul 2.
2
Rethinking dry eye disease: a perspective on clinical implications.重新审视干眼病:对临床意义的一种观点
Ocul Surf. 2014 Apr;12(2 Suppl):S1-31. doi: 10.1016/j.jtos.2014.02.002. Epub 2014 Feb 13.
3
Changes in the tear film and ocular surface from dry eye syndrome.干眼综合征导致的泪膜和眼表变化。
Prog Retin Eye Res. 2004 Jul;23(4):449-74. doi: 10.1016/j.preteyeres.2004.04.003.
4
Molecular and cellular biomarkers in dry eye disease and ocular allergy.干眼和眼过敏的分子和细胞生物标志物。
Curr Opin Allergy Clin Immunol. 2012 Oct;12(5):523-33. doi: 10.1097/ACI.0b013e328357b488.
5
The correlation between the tear film lipid layer and dry eye disease.泪膜脂质层与干眼疾病之间的相关性。
Surv Ophthalmol. 2007 Jul-Aug;52(4):369-74. doi: 10.1016/j.survophthal.2007.04.009.
6
Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.功能性泪液综合征:治疗建议的德尔菲法。
Cornea. 2006 Sep;25(8):900-7. doi: 10.1097/01.ico.0000214802.40313.fa.
7
The Ocular Protection Index.眼保护指数。
Cornea. 2008 Jun;27(5):509-13. doi: 10.1097/ICO.0b013e31816583f6.
8
Management of dry eye disease.干眼症的管理
Am J Manag Care. 2008 Apr;14(3 Suppl):S88-101.
9
Dry eye disease: pathophysiology, classification, and diagnosis.干眼病:病理生理学、分类及诊断
Am J Manag Care. 2008 Apr;14(3 Suppl):S79-87.
10
Mucins in contact lens wear and dry eye conditions.隐形眼镜佩戴和干眼状况中的黏蛋白
Optom Vis Sci. 2008 Aug;85(8):631-42. doi: 10.1097/OPX.0b013e3181819f25.

引用本文的文献

1
Pediatric Sjögren's Syndrome: Focus on Ocular Involvement and Diagnostic Challenges.小儿干燥综合征:聚焦眼部受累及诊断挑战
Medicina (Kaunas). 2025 Jun 23;61(7):1128. doi: 10.3390/medicina61071128.
2
The relation between corneal optical quality and clinical ocular surface manifestations in Chinese female with Sjogren's syndrome dry eye.中国干燥综合征干眼女性患者角膜光学质量与临床眼表表现的关系
BMC Ophthalmol. 2025 Jul 8;25(1):399. doi: 10.1186/s12886-025-04225-2.
3
Computational insights and study of drugs for dry eye disease through QSPR and MCDM approaches using topological indices.
通过使用拓扑指数的定量构效关系(QSPR)和多准则决策(MCDM)方法对干眼症药物进行计算洞察与研究。
Sci Rep. 2025 Jul 1;15(1):22245. doi: 10.1038/s41598-025-04174-2.
4
Dry eye and systemic diseases.干眼与全身性疾病。
Saudi J Ophthalmol. 2025 Jan 2;39(1):5-13. doi: 10.4103/sjopt.sjopt_182_24. eCollection 2025 Jan-Mar.
5
Overview of Dry Eye Disease for Primary Care Physicians.基层医疗医生的干眼病概述
Medicina (Kaunas). 2025 Mar 6;61(3):460. doi: 10.3390/medicina61030460.
6
Dry eye: A hospital-based sociodemographic, risk and clinical classification profile.干眼症:基于医院的社会人口统计学、风险及临床分类概况
Health SA. 2025 Feb 21;30:2793. doi: 10.4102/hsag.v30i0.2793. eCollection 2025.
7
Therapeutic Potential of Crocin and Nobiletin in a Mouse Model of Dry Eye Disease: Modulation of the Inflammatory Response and Protection of the Ocular Surface.西红花苷和川陈皮素在干眼症小鼠模型中的治疗潜力:炎症反应的调节及眼表保护
Iran J Pharm Res. 2024 Sep 15;23(1):e149463. doi: 10.5812/ijpr-149463. eCollection 2024 Jan-Dec.
8
Ultrafast adaptive optics for imaging the living human eye.用于活体人眼成像的超快速自适应光学。
Nat Commun. 2024 Nov 29;15(1):10409. doi: 10.1038/s41467-024-54687-z.
9
Copolymerized Polymers Based on Cyclodextrins and Cationic Groups Enhance Therapeutic Effect of Rebamipide in the N-Acetylcysteine-Treated Dry Eye Model.基于环糊精和阳离子基团的共聚聚合物增强了 N-乙酰半胱氨酸处理的干眼模型中瑞巴派特的治疗效果。
Drug Des Devel Ther. 2024 Sep 27;18:4345-4358. doi: 10.2147/DDDT.S469445. eCollection 2024.
10
Evaluation of therapeutic efficacy of Emustil drops for ocular discomfort and tear film osmolarity using different treatment management modes under dry environmental conditions.在干燥环境条件下,使用不同的治疗管理模式评估 Emustil 滴眼液治疗眼部不适和泪膜渗透压的疗效。
BMC Ophthalmol. 2024 Mar 25;24(1):129. doi: 10.1186/s12886-024-03390-0.